Glycosylation of autoantibodies: Insights into the mechanisms of immune thrombocytopenia
Glycosylation of autoantibodies: Insights into the mechanisms of immune thrombocytopenia
复制标题
DOI:
10.1160/th13-04-0294
复制
发表时间:
2013-12-01
影响因子:
6.7
通讯作者:
Sachs, Ulrich J.
中科院分区:
文献类型:
--
作者:
Bakchoul, Tamam;Walek, Kathrin;Sachs, Ulrich J.
Immune thrombocytopenia (ITP) is a bleeding disorder caused by IgG autoantibodies (AAbs) directed against platelets (PLTs). IgG effector, functions depend on their Fc-constant region which undergoes post; translational glycosylation. We investigated the role of Asn279-linked N-glycan of AAbs in vitro and in vivo. AAbs were purified from ITP patients (n=15) and N-glycans were enzymatically cleaved by endoglycosidase F. The effects of native AAbs and deglycosylated AAbs were compared in vitro on enhancement of phagocytosis of platelets by monocytes and complement fixation and activation applying flow cytometry, laser scanning microscopy, and a complement consumption assay. AAb-induced platelet phagocytosis was inhibited by N-glycan cleavage (median phagocytic activity: 8% vs 0.8%, p=0.004). Seven out of 15 native AAbs bound C1q and activated complement. N-glycan cleavage significantly reduced both effects. In vivo survival of human PLTs was assessed after co-transfusion with native or N-glycan cleaved AAbs in a NOD/SCID mouse model. Injection of AAbs resulted in rapid clearance of human platelets compared to control (platelet clearance after 5h (CL5h) 75% vs 30%, p